BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17405874)

  • 1. Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis.
    Pozzi A; Ibanez MR; Gatica AE; Yang S; Wei S; Mei S; Falck JR; Capdevila JH
    J Biol Chem; 2007 Jun; 282(24):17685-95. PubMed ID: 17405874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated.
    Pozzi A; Popescu V; Yang S; Mei S; Shi M; Puolitaival SM; Caprioli RM; Capdevila JH
    J Biol Chem; 2010 Apr; 285(17):12840-50. PubMed ID: 20178979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P450 CYP2C epoxygenase and CYP4A omega-hydroxylase mediate ciprofibrate-induced PPARalpha-dependent peroxisomal proliferation.
    Gatica A; Aguilera MC; Contador D; Loyola G; Pinto CO; Amigo L; Tichauer JE; Zanlungo S; Bronfman M
    J Lipid Res; 2007 Apr; 48(4):924-34. PubMed ID: 17234604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
    Wu L; Wang W; Dai M; Li H; Chen C; Wang D
    BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
    Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
    J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
    Morimura K; Cheung C; Ward JM; Reddy JK; Gonzalez FJ
    Carcinogenesis; 2006 May; 27(5):1074-80. PubMed ID: 16377806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
    Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes.
    Kroetz DL; Yook P; Costet P; Bianchi P; Pineau T
    J Biol Chem; 1998 Nov; 273(47):31581-9. PubMed ID: 9813074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.
    Shah YM; Morimura K; Yang Q; Tanabe T; Takagi M; Gonzalez FJ
    Mol Cell Biol; 2007 Jun; 27(12):4238-47. PubMed ID: 17438130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
    Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
    Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARα activation can help prevent and treat non-small cell lung cancer.
    Skrypnyk N; Chen X; Hu W; Su Y; Mont S; Yang S; Gangadhariah M; Wei S; Falck JR; Jat JL; Zent R; Capdevila JH; Pozzi A
    Cancer Res; 2014 Jan; 74(2):621-31. PubMed ID: 24302581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
    Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells.
    Hwang YP; Won SS; Jin SW; Lee GH; Pham TH; Choi JH; Kang KW; Jeong HG
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous epoxygenases are modulators of monocyte/macrophage activity.
    Bystrom J; Wray JA; Sugden MC; Holness MJ; Swales KE; Warner TD; Edin ML; Zeldin DC; Gilroy DW; Bishop-Bailey D
    PLoS One; 2011; 6(10):e26591. PubMed ID: 22028915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.